Designing dual binding site acetylcholinesterase inhibitors ……

Goedert M, Spillantini MG 2006 A century of Alzheimer’s disease. Science., 314 :777-

781.

Guillou C, MaryA, Renko DZ, Gras E, Thal C 2000 Potent acetylcholinesterase inhibitors:

design,synthesisandstructure-activityrelationshipsofalkylenelinkedbis-galanthamine

and galanthamine-galanthaminium salts* 1. Bioorg Med Chem Lett., 10 : 637-639.

Ibach B, Haen E 2004Acetylcholinesterase inhibition inAlzheimer’s Disease. Curr Pharm

Des., 10 :231-251.

Jensen MR, Schoepfer J, Radimerski T, Massey A, Guy CT, Brueggen J, Quadt C, Buckler

A, Cozens R, Drysdale MJ 2008 NVP-AUY922: a small molecule HSP90 inhibitor

with potent antitumor activity in preclinical breast cancer models. Breast Cancer Res.,

10 :1-12.

Klebe G 2006 Virtual ligand screening: strategies, perspectives and limitations. Drug

Discov Today., 11 :580-594.

Kryger G, Harel M, Giles K, Toker L, Velan B, Lazar A, Kronman C, Barak D, Ariel

N, Shafferman A 2000 Structures of recombinant native and E202Q mutant human

acetylcholinesterase complexed with the snake-venom toxin fasciculin-II. Acta

Crystallogr. Sec. D 56: 1385-1394.

Law R, Barker O, Barker JJ, Hesterkamp T, Godemann R, Andersen O, Fryatt T, Courtney

S, Hallett D, Whittaker M 2009 The multiple roles of computational chemistry in

fragment-based drug design. J Comput-Aided Mol Des., 23: 459-473.

Lewell XQ, Judd DB, Watson SP, Hann MM 1998 RECAP retrosynthetic combinatorial

analysis procedure: a powerful new technique for identifying privileged molecular

fragments with useful applications in combinatorial chemistry. J Chem Inf Comput Sci.,

38 :511-522.

Mizutani MY, Itai A 2004 Efficient Method for High-Throughput Virtual Screening Based

on Flexible Docking: Discovery of NovelAcetylcholinesterase Inhibitors. J Med Chem.,

47 :4818-4828.

Nienaber VL, Richardson PL, Klighofer V, Bouska JJ, Giranda VL, Greer J 2000

Discovering novel ligands for macromolecules using X-ray crystallographic screening.

Nat Biotechnol., 18 :1105-1107.

Pang YP, Quiram P, Jelacic T, Hong F, Brimijoin S 1996 Highly potent, selective, and

low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase. J Biol Chem., 271 :

23646-23649.

Querfurth HW, LaFerla FM 2010 Mechanisms of disease. N Engl J Med., 362 :329-344.

Racchi M, Mazzucchelli M, Porrello E, Lanni C, Govoni S 2004 Acetylcholinesterase

inhibitors: novel activities of old molecules. Pharmacol Res., 50 :441-451.

Rees DC, Congreve M, Murray CW, Carr R 2004 Fragment-based lead discovery. Nat Rev

Drug Discovery., 3 :660-672.

Reyes AE, Chacón MA, Dinamarca MC, Cerpa W, Morgan C, Inestrosa NC 2004

Acetylcholinesterase-A {beta} Complexes Are More Toxic than A {beta} Fibrils in

Rat Hippocampus: Effect on Rat {beta}-Amyloid Aggregation, Laminin Expression,

Reactive Astrocytosis, and Neuronal Cell Loss. Am J Pathol., 164 :2163-2174.

Int. J. Bioinformatics and Biological Sci.: v.2 n.1&2, p. 111-126. March & June 2014

125